{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:15:38Z","timestamp":1792156538409,"version":"4.4.0"},"reference-count":34,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2023,6,27]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Atrial cardiomyopathy (AC) is an emerging concept explaining the pathophysiology of cardioembolic strokes in absence of atrial fibrillation (AF). A definition based on the presence of electrical abnormality (P-wave terminal force in lead V1 (PTFV1) &gt;5000 \u00b5V\u00d7ms), N-Terminal pro-B-type natriuretic peptide (NT pro BNP) &gt;250\u2009pg\/mL and\/or indexed left atrial diameter (LADI) &gt;3\u2009cm\/m\u00b2 is currently tested in the ARCADIA (AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke) trial. We set out to estimate the prevalence of AC as defined in the ARCADIA trial, its determinants and its association with AF detected after stroke (AFDAS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Stepwise screening for silent Atrial Fibrillation After Stroke (SAFAS) study prospectively included 240 ischaemic stroke patients. AC markers were complete for 192 of them and 9 were not included in this analysis because AF had been diagnosed on admission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 183 patients were analysed, of whom 57% (104 patients) met the AC criteria (79 NT-proBNP, 47 PTFV1, 4 LADI). In the multivariate logistic regression, C reactive protein &gt;3\u2009mg\/L (OR (95%\u2009CI) 2.60 (1.30 to 5.21), p=0.007) and age (OR (95%\u2009CI) 1.07 (1.04 to 1.10), p&lt;0.001) were found to be independently associated with AC. After 6 months of follow-up, AFDAS was detected in 33% of AC patients and in 14% of the remaining ones (p=0.003). However, AC was not independently associated with AFDAS, contrary to left atrial volume index (&gt;34\u2009mL\/m<jats:sup>2<\/jats:sup>, OR 2.35 (CI 1.09 to 5.06) p=0029).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>AC as defined in ARCADIA is mostly based on NT pro BNP elevation (76% of patients) and is associated with age and inflammation. Moreover, AC was not independently associated with AFDAS at follow-up. The ARCADIA trial, which compares aspirin to apixaban in patients with embolic strokes of undetermined source with AC markers and must, therefore be analysed in the light of these limitations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03570060\">NCT03570060<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2023-002447","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T12:21:16Z","timestamp":1688991676000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Distribution of atrial cardiomyopathy markers and association with atrial fibrillation detected after ischaemic stroke in the SAFAS study"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03570060","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-9204","authenticated-orcid":false,"given":"Romain","family":"Didier","sequence":"first","affiliation":[{"name":"Cardiology, CHU Dijon Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Garnier","sequence":"additional","affiliation":[{"name":"Dijon Stroke Registry, Department of Neurology, University Hospital Centre Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Duloquin","sequence":"additional","affiliation":[{"name":"Dijon Stroke Registry, Department of Neurology, University Hospital Centre Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Meloux","sequence":"additional","affiliation":[{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Sagnard","sequence":"additional","affiliation":[{"name":"Cardiology, CHU Dijon Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Graber","sequence":"additional","affiliation":[{"name":"Dijon Stroke Registry, Department of Neurology, University Hospital Centre Dijon, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Dogon","sequence":"additional","affiliation":[{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Benali","sequence":"additional","affiliation":[{"name":"Cardiology, CHU Saint Etienne, Saint Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Pommier","sequence":"additional","affiliation":[{"name":"Cardiology, CHU Dijon Bourgogne, Dijon, France"},{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Laurent","sequence":"additional","affiliation":[{"name":"Cardiology, CHU Dijon Bourgogne, Dijon, France"},{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vergely","sequence":"additional","affiliation":[{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-7072","authenticated-orcid":false,"given":"Yannick","family":"Bejot","sequence":"additional","affiliation":[{"name":"Dijon Stroke Registry, Department of Neurology, University Hospital Centre Dijon, Dijon, France"},{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Guenancia","sequence":"additional","affiliation":[{"name":"Cardiology, CHU Dijon Bourgogne, Dijon, France"},{"name":"PEC 2, Universit\u00e9 de Bourgogne, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"2025082410092133000_9.2.165.1","article-title":"Cryptogenic stroke and atrial fibrillation","volume":"371","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"2025082410092133000_9.2.165.2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.016414"},{"key":"2025082410092133000_9.2.165.3","doi-asserted-by":"crossref","first-page":"949213","DOI":"10.3389\/fcvm.2022.949213","article-title":"Multimodal approach for the prediction of atrial fibrillation detected after stroke: SAFAS study","volume":"9","author":"Garnier","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025082410092133000_9.2.165.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.05.028"},{"key":"2025082410092133000_9.2.165.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.02.008"},{"key":"2025082410092133000_9.2.165.6","doi-asserted-by":"publisher","DOI":"10.2217\/fca.15.22"},{"key":"2025082410092133000_9.2.165.7","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"379","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"2025082410092133000_9.2.165.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813959"},{"key":"2025082410092133000_9.2.165.9","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.2070","article-title":"Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial \u2013 update of patient characteristics and study timeline after interim analysis","volume":"42","author":"Poli","year":"2021","journal-title":"Eur Heart J"},{"key":"2025082410092133000_9.2.165.10","doi-asserted-by":"crossref","DOI":"10.1161\/str.54.suppl_1.31","article-title":"Abstract 31: the ATTICUS randomized controlled trial - subgroup analyses","volume":"54","author":"Poli","year":"2023","journal-title":"Stroke"},{"key":"2025082410092133000_9.2.165.11","doi-asserted-by":"publisher","DOI":"10.1177\/1747493018799981"},{"key":"2025082410092133000_9.2.165.12","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318296aeca"},{"key":"2025082410092133000_9.2.165.13","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev014"},{"key":"2025082410092133000_9.2.165.14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006364"},{"key":"2025082410092133000_9.2.165.15","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000185682.09981.26"},{"key":"2025082410092133000_9.2.165.16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009989"},{"key":"2025082410092133000_9.2.165.17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24482"},{"key":"2025082410092133000_9.2.165.18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, NT-pro BNP, and incidence of stroke: the Atherosclerosis Risk in Communities (ARIC) Sudy","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke J Cereb Circ"},{"key":"2025082410092133000_9.2.165.19","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.004712"},{"key":"2025082410092133000_9.2.165.20","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.675942"},{"key":"2025082410092133000_9.2.165.21","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12126"},{"key":"2025082410092133000_9.2.165.22","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008711"},{"key":"2025082410092133000_9.2.165.23","doi-asserted-by":"publisher","DOI":"10.4065\/79.8.1008"},{"key":"2025082410092133000_9.2.165.24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2022.01.024","article-title":"Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: a systematic review","volume":"99","author":"Stalikas","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2025082410092133000_9.2.165.25","doi-asserted-by":"crossref","DOI":"10.1161\/str.51.suppl_1.26","article-title":"Abstract 26: predictors of atrial cardiopathy among patients in the Arcadia trial: an analysis of the first 924 patients","volume":"51","author":"Elkind","year":"2020","journal-title":"Stroke"},{"key":"2025082410092133000_9.2.165.26","doi-asserted-by":"publisher","DOI":"10.4065\/76.5.467"},{"key":"2025082410092133000_9.2.165.27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000508211","article-title":"Left atrial volume index predicts new-onset atrial fibrillation and stroke recurrence in patients with embolic stroke of undetermined source","volume":"49","author":"Tan","year":"2020","journal-title":"Cerebrovasc Dis"},{"key":"2025082410092133000_9.2.165.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.07.027"},{"key":"2025082410092133000_9.2.165.29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.echo.2022.05.018","article-title":"Diagnostic and prognostic value of left atrial function in identification of cardioembolism and prediction of outcomes in patients with cryptogenic stroke","volume":"35","author":"Bhat","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082410092133000_9.2.165.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.08.015"},{"key":"2025082410092133000_9.2.165.31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ijcard.2011.11.099","article-title":"Osteoprotegerin\/RANK\/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation","volume":"166","author":"Cao","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025082410092133000_9.2.165.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.03.014"},{"key":"2025082410092133000_9.2.165.33","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034777"},{"key":"2025082410092133000_9.2.165.34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/23969873221138197","article-title":"Incremental value of the combined brain-cardiac CT protocol on prediction of atrial fibrillation after stroke","volume":"8","author":"Braillon","year":"2023","journal-title":"Eur Stroke J"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2023-002447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:09:28Z","timestamp":1756055368000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2023-002447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,30]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/svn-2023-002447"],"URL":"https:\/\/doi.org\/10.1136\/svn-2023-002447","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}